UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): February 19, 2008
Winner Medical Group Inc.
(Exact name of registrant as specified in its charter)
| Nevada | | 000-16547 | | 33-0215298 |
| | | | | |
| (State of Incorporation) | | (Commission File No.) | | (IRS Employer ID No.) |
Winner Industrial Park, Bulong Road
Longhua, Shenzhen City, 518109
People’s Republic of China
(Address of Principal Executive Offices)
(86-755) 28138888
Registrant’s Telephone Number, Including Area Code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. REGULATION FD DISCLOSURE
On February 20, 2008 the Registrant intends to make a slide presentation at a Roth Capital investor meeting in Orange City, CA, U.S., a copy of which presentation and company factsheet are filed herewith as Exhibit 99.1 and Exhitit 99.2, and are incorporated herein by reference.
The information contained in this Current Report on Form 8-K and the exhibits attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information or such exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in or exhibits to this Form 8-K shall not be deemed an admission as to the materiality of any information in this report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
| EXHIBITS | | | |
| | | | |
| 99.1 | | | Slide Presentation of Winner Medical Group Inc., dated Feburary 19, 2008 | |
| 99.2 | | | Factsheet of Winner Medical Group Inc., dated February 19, 2008 | |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Winner Medical Group Inc.
| | | | |
| Date: February 19, 2008 | | | |
| | | | |
| /s/ Jianquan Li | | | |
President and Chief Executive Office | | | |
| | | | |
